MRD-negative duration following latest line of therapy predicts long-term PFS in real-world patients with multiple myeloma by Lucia Y. Chen, Santiago Thibaud, Saoirse Bodnar, Ajai Chari, Joshua Richter, Hearn Jay Cho, Larysa J. Sanchez, Cesar Rodriguez, Adriana C. Rossi, Shambavi Richard, Samir Parekh, Sundar Jagannath

Get full text

Phase 1 study combining elotuzumab with autologous stem cell transplant and lenalidomide for multiple myeloma by Seunghee Kim-Schulze, Sundar Jagannath, Sacha Gnjatic, Ajai Chari, Samir Parekh, Keren Osman, Selma Bekri, Hearn Jay Cho, David G Coffey, Adolfo Aleman, Simone Kats, Amishi Dhadwal, Donna Catamero

Get full text

Delayed neutrophil recovery following BCMA CAR-T therapy in Duffy-null myeloma does not impact severe infections or survival by Zachary M. Avigan, Saoirse Bodnar, Darren Pan, Jerrel Catlett, Joshua Richter, Larysa J. Sanchez, Cesar Rodriguez, Adriana C. Rossi, Shambavi Richard, Sundar Jagannath, Hearn Jay Cho, Samir Parekh, Santiago Thibaud

Get full text

Impact of lenalidomide-bortezomib-dexamethasone induction on patients with newly diagnosed multiple myeloma and renal impairment: Results from the Connect® MM Registry by Sikander Ailawadhi, Hans C. Lee, James Omel, Kathleen Toomey, James W. Hardin, Cristina J. Gasparetto, Sundar Jagannath, Robert M. Rifkin, Brian G. M. Durie, Mohit Narang, Howard R. Terebelo, Prashant Joshi, Ying-Ming Jou, Jorge Mouro, Edward Yu, Rafat Abonour

Get full text